O'Donnell Niall is a director of Reneo Pharmaceuticals, Inc.
Person profile
Roles
Reneo Pharmaceuticals
Director
Spruce Biosciences
Director
Address
ST. Louis, Missouri
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
144
Mirum Pharmaceuticals, Inc.
6 Sep 23
4
Reneo Pharmaceuticals, Inc.
8 Jun 23
4
SPRUCE BIOSCIENCES, INC.
26 May 23
4
SPRUCE BIOSCIENCES, INC.
16 May 23
4
Reneo Pharmaceuticals, Inc.
10 May 23
4
Mirum Pharmaceuticals, Inc.
15 Nov 22
4
Mirum Pharmaceuticals, Inc.
6 Jun 22
4
Reneo Pharmaceuticals, Inc.
3 Jun 22
4
SPRUCE BIOSCIENCES, INC.
27 May 22
4
Mirum Pharmaceuticals, Inc.
8 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 23 | RPHM Reneo Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 9.01 | 17,500 | 157.68 k | 17,500 |
25 May 23 | SPRB Spruce Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 2.26 | 30,000 | 67.80 k | 30,000 |
8 May 23 | RPHM Reneo Pharmaceuticals | Common Stock | Buy | Acquire P | Yes | No | 8 | 125,000 | 1.00 mm | 2,188,713 |